Search Results - "proteins"

Refine Results
  1. 2001

    Cellular and molecular toxicology

    Published 2009
    Table of Contents: “…Contents: Classification of adverse drug reactions -- How this relates to the chemical structure of the offending drug -- Understanding how variation in drug metabolism can contribute to clinical toxicity is important in designing pre-clinical models and screens -- Case studies of drugs which can form reactive metabolites and can irreversibly modify cellular protein -- Examples of structural modifications to chemicals containing toxicophores -- Novel and traditional serum and cellular biomarkers of adaptation, apoptosis and necrosis.…”
    Get full text
    Series
    Electronic Video
  2. 2002

    Mechanistic aspects and therapeutic applications of RNAi

    Published 2007
    Table of Contents: “…Contents: RNAi mechanisms -- RNAi and HIV infection -- Lentiviral vector-mediated transduction of stem cells and T-cells -- Gene therapy based treatment of HIV-1 -- HIV mutants that abrogate RNAi -- Multiplexing different siRNAs and siRNAs with other antiviral RNAs to minimize viral resistance -- An HIV Tat inducible shRNA expression system -- Multiplexing shRNA with dominant negative M10 protein inhibition of HIV.…”
    Get full text
    Series
    Electronic Video
  3. 2003

    Mechanistic aspects and therapeutic applications of RNAi

    Published 2007
    Table of Contents: “…Contents: RNAi mechanisms -- RNAi and HIV infection -- Lentiviral vector-mediated transduction of stem cells and T-cells -- Gene therapy based treatment of HIV-1 -- HIV mutants that abrogate RNAi -- Multiplexing different siRNAs and siRNAs with other antiviral RNAs to minimize viral resistance -- An HIV Tat inducible shRNA expression system -- Multiplexing shRNA with dominant negative M10 protein inhibition of HIV.…”
    Get full text
    Series
    Electronic Video
  4. 2004

    Cellular and molecular toxicology

    Published 2009
    Table of Contents: “…Contents: Classification of adverse drug reactions -- How this relates to the chemical structure of the offending drug -- Understanding how variation in drug metabolism can contribute to clinical toxicity is important in designing pre-clinical models and screens -- Case studies of drugs which can form reactive metabolites and can irreversibly modify cellular protein -- Examples of structural modifications to chemicals containing toxicophores -- Novel and traditional serum and cellular biomarkers of adaptation, apoptosis and necrosis.…”
    Get full text
    Series
    Electronic Video
  5. 2005

    Molecular polymorphism of man structural and functional individual multiformity of biomacromolecules /

    Published 2011
    Table of Contents: “….] -- Biomedical aspects in investigations of biochemical polymorphism of actins and some actin-binding proteins / S.S. Shishkin ... [et al.] -- Molecular mechanisms of adaptation : stress and aggression / A.G. …”
    An electronic book accessible through the World Wide Web; click to view
    Electronic eBook
  6. 2006

    Sugarcane : physiology, biochemistry, and functional biology /

    Published 2014
    Table of Contents: “…Sugarcane: the crop, the plant, and domestication -- Anatomy and morphology -- Developmental stages (phenology) -- Ripening and postharvest deterioration -- Mineral nutrition of sugarcane -- Photosynthesis in sugarcane -- Respiration as a competitive sink for sucrose accumulation in sugarcane culm: perspectives and open questions -- Nitrogen physiology of sugarcane -- Water relations and cell expansion of storage tissue -- Water, transpiration, and gas exchange -- Transport proteins in plant growth and development -- Phloem transport of resources -- Cell walls: structure and biogenesis -- Hormones and growth regulators -- Flowering -- Stress physiology: abiotic stresses -- Mechanisms of resistance to pests and pathogens in sugarcane and related crop species -- Source and sink physiology -- Biomass and bioenergy -- Crop models -- Sugarcane yields and yield-limiting processes -- Systems biology and metabolic modeling -- Sugarcane genetics and genomics -- Sugarcane biotechnology: axenic culture, gene transfer, and transgene expression.…”
    An electronic book accessible through the World Wide Web; click to view
    Electronic eBook
  7. 2007

    Drug discovery and target validation in the p53 pathway

    Published 2009
    Table of Contents: “…Contents: Controlling cancer -- p53 discovery -- Oncoproteins -- SV40, Adeno and HPV -- The p53 protein -- Incidence of genetic changes in p53 in human cancers -- What does p53 do? …”
    Get full text
    Series
    Electronic Video
  8. 2008

    Discovery of Levetiracetam (Keppra(R)) the first SV2A ligand for the treatment of epilepsy /

    Published 2013
    Table of Contents: “…Contents: Levetiracetam -- Antiepileptic Drug Discovery -- Levetiracetam in electroshock and PTZ seizures -- Protection against seizures in rat model -- Levetiracetam activity in GAERS model -- Impact on cognitive function -- Hyper-synchronization / excitability inhibition in vitro -- Effect on development of amygdala kindling -- Effect on seizures in genetic models of epilepsy -- Inactivation of sodium channels -- Reduction of current through T-type Ca channels -- Levetiracetam mechanism of action -- SV2 proteins: candidates for the LEV binding site -- SV2A cloning and binding studies -- Levetiracetam studies in SV2A (+/-) mice -- Profile of new class of antiepileptic drugs.…”
    Get full text
    Series (Drug discovery and development in the neurosciences)
    Series (Small molecule drug discovery)
    Electronic Video
  9. 2009

    Drug discovery and target validation in the p53 pathway

    Published 2009
    Table of Contents: “…Contents: Controlling cancer -- p53 discovery -- Oncoproteins -- SV40, Adeno and HPV -- The p53 protein -- Incidence of genetic changes in p53 in human cancers -- What does p53 do? …”
    Get full text
    Series
    Electronic Video
  10. 2010

    Drug discovery and target validation in the p53 pathway

    Published 2009
    Table of Contents: “…Contents: Controlling cancer -- p53 discovery -- Oncoproteins -- SV40, Adeno and HPV -- The p53 protein -- Incidence of genetic changes in p53 in human cancers -- What does p53 do? …”
    Get full text
    Series
    Electronic Video
  11. 2011

    Discovery of Levetiracetam (Keppra(R)) the first SV2A ligand for the treatment of epilepsy /

    Published 2013
    Table of Contents: “…Contents: Levetiracetam -- Antiepileptic Drug Discovery -- Levetiracetam in electroshock and PTZ seizures -- Protection against seizures in rat model -- Levetiracetam activity in GAERS model -- Impact on cognitive function -- Hyper-synchronization / excitability inhibition in vitro -- Effect on development of amygdala kindling -- Effect on seizures in genetic models of epilepsy -- Inactivation of sodium channels -- Reduction of current through T-type Ca channels -- Levetiracetam mechanism of action -- SV2 proteins: candidates for the LEV binding site -- SV2A cloning and binding studies -- Levetiracetam studies in SV2A (+/-) mice -- Profile of new class of antiepileptic drugs.…”
    Get full text
    Series (Drug discovery and development in the neurosciences)
    Series (Small molecule drug discovery)
    Electronic Video
  12. 2012

    Muscle aging inclusion-body myositis and myopathies /

    Published 2012
    Table of Contents: “…King Engel, Shalini Mahajan, Valerie Askanas -- Mitochondrial changes in ageing with particular reference to muscle, and possible clinical consequences / Salvatore DiMauro, Eric Schon, Michio Hirano -- Protein degradation in ageing cells and mitochondria : relevance to the neuromuscular system / Jenny Ngo and Kelvin Davies -- Human muscle protein metabolism in relation to exercise and aging : potential therapeutic applications / Micah J. …”
    An electronic book accessible through the World Wide Web; click to view
    Electronic eBook
  13. 2013

    Werner & Ingbar's the thyroid : a fundamental and clinical text /

    Published 2013
    Table of Contents: “…The heritage of the thyroid: a brief history -- Development of the hypothalamic-pituitary-thyroid axis -- Anatomy and pathology of the thyrotrophs -- Thyroid hormone synthesis: thyroid iodide transport -- Thyroid hormone synthesis -- Thyroglobulin structure, function, and biosynthesis -- Thyroid hormone transport proteins and the physiology of hormone binding -- Intracellular pathways of iodothyronine metabolism/implications of deiodination for thyroid hormone action -- Genomic and nongenomic actions of thyroid hormones -- Thyroid hormones structure-function relationships -- Chemistry and biosynthesis of thyrotropin -- The thyrotropin receptor -- Regulation of thyrotropin secretion -- Age related changes in thyroid function -- Effects of drugs on TSH secretion, thyroid hormones absorption, synthesis, metabolism, and action -- Nonthyroidal illness syndrome -- Iodine deficiency and endemic cretinism -- Effect of excess iodide: clinical aspects -- Thyroid radionuclide uptake and imaging studies -- Measuring serum thyroid-stimulating hormone, thyroid hormones, thyroid-directed antibodies, and transport proteins -- Measurement of thyroglobulin -- Nonisotopic techniques of thyroid imaging -- Physical examination of the thyroid gland -- Pathology and cytopathology -- Introduction to thyrotoxicosis -- Pathogenesis of graves' disease -- Ophthalmopathy -- Thyroid dermopathy and thyroid acropachy -- Thyrotropin-induced thyrotoxicosis -- Toxic adenoma and toxic multinodular goiter -- Trophoblastic tumors -- Sporadic painless, painful subacute and acute infectious thyroiditis -- Thyrotoxicosis of extrathyroid origin -- Overview of the clinical manifestations of thyrotoxicosis -- The cardiovascular system in thyrotoxicosis -- Thyroid hormones in thermogenesis, intermediary metabolism, and obesity -- The male and female reproductive system in thyrotoxicosis -- The skeletal system in thyrotoxicosis -- Behavioral and psychiatric aspects of thyrotoxicosis --…”
    An electronic book accessible through the World Wide Web; click to view
    Electronic eBook
  14. 2014

    Agricultural wastes

    Published 2009
    Table of Contents: “…Potential risk and environmental benefits of waste derived from animal agriculture / Ajit K Sarmah -- Animal waste and hazardous substances: current laws and legislative issues / Claudia Copeland -- Reprocessing and protein enrichment of agricultural wastes by thermophilic aerobic digestion (TAD) / J. …”
    An electronic book accessible through the World Wide Web; click to view
    Electronic eBook
  15. 2015

    The blood-brain barrier new research /

    Published 2012
    Table of Contents: “….] -- It takes two to tango : protein-protein interactions in the translocation of pathogens across blood-brain barrier / L. …”
    An electronic book accessible through the World Wide Web; click to view
    Electronic eBook
  16. 2016

    Hepatic encephalopathy in cirrhosis a disorder of glial-neuronal signalling /

    Published 2013
    Table of Contents: “…Contents: Classification of hepatic encephalopathy -- Hepatic encephalopathy in cirrhosis -- Transjugular intrahepatic portosystemic shunt (TIPS) -- Hepatic encephalopathy post-TIPS -- Neuropathology of hepatic encephalopathy in chronic liver failure -- Cirrhosis-related Parkinsonism -- PET studies in cirrhosis -- Neuroinflammation and hepatic encephalopathy in cirrhosis -- Systemic inflammatory response syndrome (SIRS) in cirrhosis -- Translocator protein and hepatic encephalopathy in cirrhosis -- Modulatory site for neurosteroids -- Prevention and treatment of hepatic encephalopathy in cirrhosis -- Emerging new therapeutic approaches.…”
    Get full text
    Series
    Electronic Video
  17. 2017

    Experimental therapies in Alzheimer's disease the development and use of mouse models /

    Published 2007
    Table of Contents: “…Contents: Animal models and AD research -- Role in identifying pathological pathways, biomarkers and candidate therapies -- Design of models and associated technical parameters -- Process of transgenesis -- Developing mouse models for beta-amyloid precursor protein mutations -- TgCRND8 mice -- Transgenic approaches for investigating Tau mutations -- Exploring environmental modifiers of beta-amyloid pathobiology -- Candidate chemical risk-factor for sporadic AD -- Potential of ''smart'' beta-amyloid-directed interventions.…”
    Get full text
    Series
    Electronic Video
  18. 2018

    Hepatic encephalopathy in cirrhosis a disorder of glial-neuronal signalling /

    Published 2013
    Table of Contents: “…Contents: Classification of hepatic encephalopathy -- Hepatic encephalopathy in cirrhosis -- Transjugular intrahepatic portosystemic shunt (TIPS) -- Hepatic encephalopathy post-TIPS -- Neuropathology of hepatic encephalopathy in chronic liver failure -- Cirrhosis-related Parkinsonism -- PET studies in cirrhosis -- Neuroinflammation and hepatic encephalopathy in cirrhosis -- Systemic inflammatory response syndrome (SIRS) in cirrhosis -- Translocator protein and hepatic encephalopathy in cirrhosis -- Modulatory site for neurosteroids -- Prevention and treatment of hepatic encephalopathy in cirrhosis -- Emerging new therapeutic approaches.…”
    Get full text
    Series
    Electronic Video
  19. 2019

    Experimental therapies in Alzheimer's disease the development and use of mouse models /

    Published 2007
    Table of Contents: “…Contents: Animal models and AD research -- Role in identifying pathological pathways, biomarkers and candidate therapies -- Design of models and associated technical parameters -- Process of transgenesis -- Developing mouse models for beta-amyloid precursor protein mutations -- TgCRND8 mice -- Transgenic approaches for investigating Tau mutations -- Exploring environmental modifiers of beta-amyloid pathobiology -- Candidate chemical risk-factor for sporadic AD -- Potential of ''smart'' beta-amyloid-directed interventions.…”
    Get full text
    Series
    Electronic Video
  20. 2020

    Experimental therapies in Alzheimer's disease the development and use of mouse models /

    Published 2007
    Table of Contents: “…Contents: Animal models and AD research -- Role in identifying pathological pathways, biomarkers and candidate therapies -- Design of models and associated technical parameters -- Process of transgenesis -- Developing mouse models for beta-amyloid precursor protein mutations -- TgCRND8 mice -- Transgenic approaches for investigating Tau mutations -- Exploring environmental modifiers of beta-amyloid pathobiology -- Candidate chemical risk-factor for sporadic AD -- Potential of ''smart'' beta-amyloid-directed interventions.…”
    Get full text
    Series
    Electronic Video